dBlood donor samples (1,007) were assessed for anti-phenolic glycolipid 1 (PGL-1) IgM antibodies and Mycobacterium leprae DNA presence, which had 3.8% and 0.3% positivity, respectively. After a 5-year follow-up period, six individuals with positive markers developed leprosy, raising the hypothesis that asymptomatic infection among blood donors may be an undisclosed mode of leprosy transmission via transfusion.
Leprosy is one of the oldest infectious diseases known to affect humans and remains a public health issue, particularly in Brazil, which accounts for almost all new cases detected in the Americas (1).Untreated leprosy patients are considered the main source of transmission. However, the dichotomy between the highly effective treatment and the occurrence of new cases among people without previous contact with patients indicates that other infectious sources must be investigated (2).The majority of exposed individuals will not develop the disease, although cumulative evidence demonstrates widespread dissemination of bacilli in regions where leprosy is endemic, strengthening the hypothesis that asymptomatic individuals are involved in the Mycobacterium leprae chain of transmission (3).Serological reactivity to M. leprae antigens has been used as an immunological marker for exposure and infection (4). Seropositivity for antibodies against phenolic glycolipid 1 (PGL-1), M. leprae-specific cell surface antigenic molecule has been correlated to a greater chance for later onset of leprosy among household contacts of leprosy patients (5).Studies regarding the detection of M. leprae DNA in peripheral blood samples are scarce. It has recently been suggested that whole-blood nested-PCR amplification could be used for early diagnosis of leprosy (6) and that the presence of M. leprae DNA in peripheral blood may be associated with bacillary migration and a high risk for disease onset (7).There are no published data on the assessment of randomly selected healthy blood donors for any kind of M. leprae marker. Therefore, this is the first epidemiological study to assess donor blood samples for the presence of antibodies against M. leprae and bacillary DNA through enzyme-linked immunosorbent assay (ELISA) and real-time PCR, respectively.Subjects were screened from a population of 1,035 blood donors at the regional blood bank of Uberlandia, Minas Gerais, Brazil. All subjects had normal dermatoneurological clinical examinations, and 28 people who reported prior contact with leprosy patients were excluded from the study. The reported new-case detection rate in the Uberlandia region was 11 per 100,000 population.A total of 1,007 peripheral blood samples were assessed for the presence of anti-PGL-1 antibodies and M. leprae DNA. Indirect ELISA against M. leprae native PGL-1 molecule was applied to detect specific IgM antibodies in serum samples, according to previously described methodology (4). Detection of DNA was performed with a species-specific TaqMan primer/probe assay targeting the repetitive region RLEP element of disperse...